Ligand Pharma (LGND) Tops Q2 EPS by 25c, Beats on Revenues; Boosts FY18 EPS/Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. HUBS
3. SPY
4. AAPL
5. RARE
6. INTU
7. AUTO
8. AZN
9. BETR
10. TRMD

Go back to Ligand Pharma (LGND) Tops Q2 EPS by 25c, Beats on Revenues; Boosts FY18 EPS/Revenue Outlook
LIGAND PHARMA (NASDAQ: LGND) Delayed: 284.70 --0 (-0%)
Previous Close $284.70    52 Week High $139.79 
Open $284.70    52 Week Low $82.07 
Day High $284.70    P/E 662.09 
Day Low $284.70    EPS $0.43 
Volume 1,942